Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 9.14 Billion | USD 28.90 Billion | 12.20% | 2024 |
FrequentlyAsked Questions
Nucleic Acid Amplification Testing (NAAT) is a molecular diagnostic method used to amplify and detect specific DNA or RNA sequences for identifying pathogens, genetic changes, and cellular abnormalities with high precision and sensitivity.
The global nucleic acid amplification testing market is projected to grow due to increasing prevalence of infectious diseases, rising demand for rapid diagnostic solutions, and growing emphasis on precision medicine and personalized healthcare.
According to a study, the global nucleic acid amplification testing market size was worth around USD 9.14 billion in 2024 and is predicted to grow to around USD 28.90 billion by 2034.
The CAGR value of the nucleic acid amplification testing market is expected to be around 12.20% during 2025-2034.
North America is expected to lead the global nucleic acid amplification testing market during the forecast period.
The major players profiled in the global nucleic acid amplification testing market include Roche Diagnostics Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Qiagen N.V., Hologic Inc., bioMérieux SA, Becton Dickinson and Company, Cepheid (Danaher Corporation), GenMark Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., DiaSorin S.p.A., Siemens Healthineers AG, Bio-Rad Laboratories Inc., and Agilent Technologies Inc.
The report examines key aspects of the nucleic acid amplification testing market, including a detailed analysis of existing growth factors and restraints, as well as an examination of future growth opportunities and challenges that will impact the market.
The nucleic acid amplification testing market is being shaped by rapid technological advancements, including automation, digital PCR, isothermal amplification, and artificial intelligence, which make tests faster, more accurate, and easier to use outside of large laboratories. These innovations are expanding adoption in hospitals, clinics, and remote settings worldwide.
The nucleic acid amplification testing market is witnessing leading companies adopt strategies such as new product launches, partnerships, mergers and acquisitions, and geographic expansion to broaden test menus, improve turnaround times, and extend point-of-care availability.
The nucleic acid amplification testing market is led by the hospital and clinic segment, which holds the largest share due to high testing volumes, widespread laboratory infrastructure, and adoption of point-of-care diagnostic systems, followed by diagnostic laboratories for high-throughput applications.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed